Related Experiment Video For cutaneous tuberculosis
Updated: Sep 19, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Unique pathological features and drug resistance patterns in cutaneous tuberculosis
Yuejiao Liu1, Runrui Wu1, Junjun Liu1
1Chinese PLA Key Laboratory of Tuberculosis, Department of Pathology, The 8th Medical Center, Chinese PLA General Hospital, Beijing, China.
Abstract:
Cutaneous tuberculosis (CTB), a rare manifestation of extrapulmonary tuberculosis, often presents diagnostic challenges in clinical settings due to its atypical presentation. The definitive diagnosis relies heavily on pathological evaluation, which underscores the importance of understanding the distinct pathological characteristics and drug resistance patterns of CTB, a subject that has not been extensively explored previously. In this study, we conducted a comparative analysis of 59 CTB samples and 59 pulmonary tuberculosis samples, focusing on their clinicopathological features. Our findings reveal that CTB can be characterized by subcutaneous irregular hypoechoic regions on ultrasound, localized soft tissue swelling, and flaky low-density shadows on CT scans, with MRI effectively determining the extent of bone and soft tissue involvement. The two groups had no statistical difference in the positivity rate for acid-fast staining and molecular detection. Notably, the incidence of granulomatous lesions was higher in CTB compared to pulmonary tuberculosis, and the high number of macrophages in the skin may be an important reason. However, other parameters such as caseous necrosis, coagulative necrosis, inflammatory necrosis, acute inflammation, hemorrhage, fibroplasia, and exudation showed no significant differences between the two groups. Intriguingly, many significant differences in drug resistance patterns were found between the CTB group and the control group. But when comparing the secondary CTB group to the control group, the only significant difference found was in resistance to RFP + INH + STR. Overall, our study highlights unique pathological features and drug resistance profiles in CTB, providing valuable insights for more accurate clinical diagnosis and tailored therapeutic strategies.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

